OS Therapies Incorporated
OSTX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $3 | $4 | $1 | $1,160 |
| Gross Profit | -$3 | -$4 | -$1 | -$1,160 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,836 | $3,217 | $3,291 | $2,174 |
| G&A Expenses | $0 | $1,121 | $1,154 | $1,504 |
| SG&A Expenses | $3,975 | $1,121 | $1,154 | $1,504 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $5 | $1 | -$0 |
| Operating Expenses | $6,811 | $4,343 | $4,446 | $3,678 |
| Operating Income | -$6,814 | -$4,343 | -$4,446 | -$4,837 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2,069 | -$3,449 | -$1,808 | -$2,583 |
| Pre-Tax Income | -$8,883 | -$7,792 | -$6,255 | -$7,420 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,883 | -$7,792 | -$6,255 | -$7,420 |
| % Margin | – | – | – | – |
| EPS | -0.52 | -0.39 | -0.28 | -0.33 |
| % Growth | -33.3% | -39.3% | 15.2% | – |
| EPS Diluted | -0.52 | -0.39 | -0.28 | -0.33 |
| Weighted Avg Shares Out | 20,870 | 20,050 | 23,101 | 23,101 |
| Weighted Avg Shares Out Dil | 20,870 | 20,050 | 23,101 | 23,101 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,052 | $3,449 | $1,808 | $2,583 |
| Depreciation & Amortization | $3 | $4 | $1 | $1 |
| EBITDA | -$6,828 | -$4,338 | -$4,445 | -$4,837 |
| % Margin | – | – | – | – |